ISRCTN26119679已完成未知
A double blind randomised controlled trial of post-operative low molecular weight heparin bridging therapy versus placebo bridging therapy for patients who are at high risk for arterial thromboembolism
ondon Health Sciences Centre (Canada)0 个研究点目标入组 1,773 人开始时间: 2008年6月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,773
研究概览
简要总结
2018 results in: https://ash.confex.com/ash/2018/webprogram/Paper109964.html (added 19/02/2019)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Informed consent
- •2. Patients of either sex, 18 years and older, with prosthetic heart valves receiving long-term oral anticoagulation with warfarin, or
- •3. Patients with atrial fibrillation and a major risk factor (previous transient ischaemic attack (TIA) or stroke, high blood pressure, diabetes, 75 years and older, moderate/severe left ventricle dysfunction), who require elective non-cardiac surgery or an invasive procedure with reversal of their anticoagulant therapy
排除标准
- •1. Evidence of active bleeding prior to stopping warfarin
- •2. Platelet count less than 100 x 10^9/L
- •3. Spinal or neurosurgery
- •4. Life expectancy less than three months
- •5. Serum creatinine greater than 150 umol/L
- •6. Patients requiring cardiac surgery
- •7. Multiple prosthetic valves or Starr-Edwards valves or prosthetic valves with a history of stroke or TIA
研究者
相似试验
已完成
2 期
Effect of concomitant treatment with an androgen on sexual functioning in women using an oral contraceptioISRCTN03247616Pantarhei Bioscience BV (Netherlands)81
已完成
不适用
Studying the impact of Doxycycline on fear memory in healthy individualsISRCTN66987216Psychiatric University Hospital (Psychiatrische Universitätsklinik) Zürich (PUK ZH)160
已完成
不适用
A randomized, blinded, clinical trial assessing the efficacy of superfine merino wool base layer garments (SMWBG) in children with Atopic Dermatitis (AD) measuring SCORAD, EASI, POEM and DSA scoresAtopic dermatitisISRCTN53706986Queensland Institute of Dermatology30
已完成
不适用
A double blind, randomised, placebo controlled, multicentre trial of Anti-Tumour Necrotising Factor alpha (Anti-TNFa) chimeric monoclonal antibody (infliximab, Remicade®) in combination with methotrexate in patients with very early inflammatory arthritisEarly inflammatory arthritisMusculoskeletal DiseasesArthritisISRCTN21272423Medical University of Vienna (Austria)89
已完成
不适用
PREVAIL study - PREVenting infection using Antimicrobial Impregnated Long linesInfectious disease, preterm babies requiring a PICCNeonatal DiseasesISRCTN81931394Great Ormond Street Hospital for Children NHS Foundation Trust (UK)861